NovaBay Pharmaceuticals, Inc.
NBY
$1.03
$0.4371.67%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.92M | 7.67M | -1.21M | -1.21M | -1.59M |
| Total Depreciation and Amortization | 38.00K | 55.00K | 95.00K | 95.00K | 90.00K |
| Total Amortization of Deferred Charges | 20.00K | 26.00K | 3.00K | 145.00K | 311.00K |
| Total Other Non-Cash Items | 4.00K | 660.00K | -87.00K | 22.00K | 622.00K |
| Change in Net Operating Assets | -1.09M | 1.33M | 229.00K | -1.11M | -18.00K |
| Cash from Operations | -2.95M | 9.75M | -972.00K | -2.06M | -580.00K |
| Capital Expenditure | -- | -- | 0.00 | -2.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 0.00 | 0.00 | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | -2.00K | 0.00 |
| Total Debt Issued | -- | -- | 500.00K | -- | -- |
| Total Debt Repaid | 0.00 | -507.00K | 0.00 | -790.00K | -622.00K |
| Issuance of Common Stock | 0.00 | 614.00K | 0.00 | 2.88M | 226.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -174.00K | -1.82M | 0.00 | 0.00 | -96.00K |
| Cash from Financing | -174.00K | -1.71M | 500.00K | 2.09M | -492.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 126.00K | -- | -- |
| Net Change in Cash | -3.12M | 8.04M | -346.00K | 26.00K | -1.07M |